Skip to content
← Lobby register
IM
Trade & Business

Innovative Medicines for Luxembourg ASBL

🇪🇺 LUXEMBOURGRegistered 23/03 staff
Disclosed budget
€100,000 — €199,999
Meetings 12mo
2
Policy files
0
Accredited passes
2

Recent meetings

DateCommissioner / CabinetTopicFile
08 Sept 2025
Anne Calteux
Head of Representation
Mr Romain Labé, Secretary General of IML (Innovative Medecines for Luxembourg asbl). Promoting the innovative pharmaceutical industry in collaboration with all the key players in the Luxembourg healthcare sector.
08 Sept 2025
Anne Calteux
Head of Representation
Mr Romain Labé, Secretary General of IML (Innovative Medecines for Luxembourg asbl). Promoting the innovative pharmaceutical industry in collaboration with all the key players in the Luxembourg healthcare sector.SRC

Mission & Goals

The Innovative Medicines for Luxembourg Asbl (IML) represents the research-based pharmaceutical industry in Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation and ensures that patients benefi t from the latest medical advances. Engaging with national and European stakeholders, IML advocates for policies that support pharmaceutical research, market access, and a strong healthcare ecosystem. By facilitating dialogue between industry, policymakers, and healthcare professionals, IML contributes to shaping a dynamic and innovation-driven pharmaceutical landscape in Luxembourg, ensuring sustainable access to cutting-edge treatments.

EU Legislative Interests

EU Pharmaceutical Package, Critical Medicines Act, UWWTD, Biotech Act, PFAS

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

EFPIA pharma.be letzpact.lu Paperjam Hive Business Club Belgique Luxemboug

Organisation Members

https://www.iml.lu/en/about-us/members